Elucidating the role of weight loss and glycaemic control in patients with type 2 diabetes.

Anukriti SharmaArshiya MariamEmily ZacherleAlex MilinovichJanine BaumanDavid S SuganoJosh NooneJigar R RajpuraRobert S ZimmermanBartolome BurgueraMichael W KattanAnita D Misra-HebertKevin M Pantalone Daniel M Rotroff

Published in: Diabetes, obesity & metabolism (2024)

Antidiabetic medication-associated, and specifically GLP-1RA-associated, weight loss and HbA1c reductions independently reduce real-world clinical outcome risk.

Keyphrases

weight loss
bariatric surgery
roux en y gastric bypass
gastric bypass
type diabetes
rheumatoid arthritis
healthcare
glycemic control
obese patients
weight gain
adverse drug
emergency department
physical activity
body mass index
systemic lupus erythematosus
idiopathic pulmonary fibrosis